Use access key #2 to skip to page content.
$9.54 1.11 (13.17%)
10/13/2008 4:00 PM

Trans1 (TSON)

CAPS Rating:
*

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating TSON

Add Stock to Watchlist

What the Community Thinks

Total Members

13 Outperforms
10 Underperforms
 

All-Stars

1 Outperforms
3 Underperforms
 

Wall Street

5 Outperforms
0 Underperforms
 

Members bullish on TSON are also bullish on:

Members bearish on TSON are also bearish on:

Ticker Tags

IPO in 2007 (239), Micro Cap (4824), Medical Device (43)
Suggest a tag

Trans1 At A Glance

Current Price: $9.54
Last Trade Time: 10/13/2008 4:00 PM
Open: $8.57
Previous Close: $8.43
Daily Range: $8.57 - $9.54
52-Week Range: $6.90 - $26.48
Volume: 96,590
Market Cap: $172.56M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

TSON VS S&P 500 (SPY)

TSON 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for TSON

More Headlines...

Top Bull Pitch

Recs

2

Trans1 (TSON)

Avatar archae13 (62.51) Submitted: 10/19/07 1:58 PM

Back health is big business, and will continue to grow as baby-boom reaches retirement. This company specializes in low-back issues.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 3 of 3  

Recs

0

 (TSON)

Avatar handoverhill (< 20) Submitted: 5/28/08 5:52 AM : Underperform Start Price: $14.48 TSON Score: 6.44

This stock is in the healthcare sector of the market and the industry of medical equipment and supplies industry. It's revenues for last year 2007 totaled $16.5M and the net income fell 10% which refllects an increase in number of products sold resulted from the continued market acceptance of the Axialif products.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TSON)

Avatar stocks2grow (79.21) Submitted: 1/28/08 1:09 PM : Outperform Start Price: $14.52 TSON Score: -9.14

IPO recently, dropped since then, but seems promising long term if their plans work out.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TSON)

Avatar kernel101 (23.80) Submitted: 12/19/07 2:21 AM : Outperform Start Price: $17.93 TSON Score: -15.51

new 4

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 3 of 3  

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackStanfordRes 58.81 09/19/08 Outperform NS $8.70+7.70%-22.28%+29.98
TrackMerrimanCo < 20 04/03/08 Outperform NS $12.27-23.63%-27.28%+3.64
TrackLehmanBros 74.50 02/22/08 Outperform NS $11.25-16.71%-26.72%+10.01
TrackCowenandCo 80.80 11/26/07 Outperform NS $20.12-53.43%-31.06%-22.37
TrackWachovia < 20 11/26/07 Outperform NS $20.30-53.84%-31.52%-22.32

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners